npj Digital Medicine
The generative rearchitecture of antibody engineering shifts empirical discovery into intentional design
By Kyunghee Noh and Wonbeak Yoo.
Abstract
Abstract Generative AI is reshaping antibody engineering by transitioning from empirical screening toward more specification-driven design, potentially expanding the accessible target landscape. While front-loading developability criteria helps streamline discovery timelines, data constraints still introduce risks of in silico misprioritization. This Perspective discusses how integrating computational inference within disciplined engineering frameworks can complement traditional sampling methods, highlighting that coupling AI-driven predictions with rigorous empirical validation remains essential for achieving therapeutic intent.
Keywords
- Monoclonal and Polyclonal Antibodies Research
- Complement (music)
- Generative grammar
- Perspective (graphical)
- Inference
- Generative model
- Empirical research
- Sampling (signal processing)
- Open access
Source
Published in npj Digital Medicine. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
